Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139861 · ClinicalTrials.gov registry record · NA
Better Sleep Study
A NA study of Depression in Adolescence and Delayed Sleep Phase, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06139861: Recruiting NA study of Depression in Adolescence and Delayed Sleep Phase, sponsored by University of California, San Francisco.
NCT06139861 is a NA study of Depression in Adolescence and Delayed Sleep Phase that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants, above the 144-participant average among 7 other Depression in Adolescence trials with a reported enrollment target (39% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06139861, a NA study of Depression in Adolescence and Delayed Sleep Phase, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of adolescents with depression and a misaligned relationship between biological circadian timing and waketime utilizing a cognitive-behavioral sleep intervention.
Primary Outcome
Validated biological and behavioral assessment; range between 0 and 11 hours, with shorter numbers indicating worse alignment between circadian biology and behavior
Conditions Studied
Interventions
- BEHAVIORAL TranS-C
- BEHAVIORAL Psychoeducation
Study Locations (1)
California
- UCSF Nancy Friend Pritzker Psychiatry Building - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2028-08-01 |
| Phase | NA |
What NCT06139861 shows while recruiting
NCT06139861 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 144-participant average among 7 other Depression in Adolescence trials with a reported enrollment target (39% higher).
The record links to 2 conditions, with Depression in Adolescence appearing as the primary indexed condition, and to 2 interventions - of which TranS-C is the first listed.
NCT06139861 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06139861 about?
NCT06139861 is a clinical study titled "Better Sleep Study". The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of adolescents with depre...
What is the current status of trial NCT06139861?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-03-15. Estimated completion is 2028-08-01.
What conditions does trial NCT06139861 study?
This clinical trial studies the following conditions: Depression in Adolescence, Delayed Sleep Phase.
What interventions are being tested in trial NCT06139861?
The interventions under investigation include: TranS-C (BEHAVIORAL), Psychoeducation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06139861?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06139861 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression in Adolescence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RECRUITING · NA
-
Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
RECRUITING · NA
-
Mechanisms of Depression and Anhedonia in Adolescents: Linking Sleep to Reward- and Stress-Related Brain Function
RECRUITING · NA
-
Telehealth Behavioral Activation for Teens
RECRUITING · NA
-
Neuro-affective Response to Light in Depressed Adolescents and Young Adults
RECRUITING · NA
-
Mindfulness-Based fMRI Neurofeedback for Depression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI